Explore our comprehensive coverage of mrna, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
The August 5 FDA approval of the first mRNA-based seasonal influenza vaccine structurally reprices the $7 billion global prophylaxis market. This plat...
Read Full Story →
Medical ResearchA universal mRNA influenza vaccine targeting the conserved hemagglutinin stalk has elicited broad ne...
Medical ResearchA Phase III trial demonstrates that a personalized mRNA neoantigen vaccine combined with chemotherap...
AI & InnovationThe FDA granted full approval to the first fully AI-designed, personalized mRNA cancer vaccine, deve...
HealthA personalized mRNA vaccine developed by Moderna and Merck has reduced the recurrence of high-risk m...
